Injection, Suspension · Intramuscular

Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1n1) Antigen (Propiolactone Inactivated), Influenza A Virus A/Croatia/10136rv/2023 X-425a (H3n2) Antigen (Propiolactone Inactivated), Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Propiolactone Inactivated)

Brands: Afluria · Influenza A Virus A/Croatia/10136rv/2023 X-425a (H3n2) Antigen (Propiolactone Inactivated) + Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1n1) Antigen (Propiolactone Inactivated) + Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Propiolactone Inactivated)

0 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US2 NDCs
0 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)2718395

US makers1 labelers

Packages2

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Seqirus PTY LTD.	unknown	2	EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.